| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.33 | 0.3 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |